Pipequaline

This classification denotes an anxiolytic with the molecular formula C22H24N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J3S205V4I2, chemically known as quinoline, 2-phenyl-4-(2-(4-piperidinyl)ethyl)- but generally known as pipequaline, which bears US NIH Compound Identifier 71219. European Medicines Agency schedules Pipequaline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09865MIG. The term PIPEQUALINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). PIPEQUALINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pipequaline under HS 29334990 and SITC 51575. As of Q4 2014, PIPEQUALINE remains the US FDA Preferred Term for this commodity. Pipequaline bears US NLM identifiers UMLS ID C0071104 and NCI Concept Code C66395. SMILES: N1CCC(CC1)CCC1C2C(NC(C1)C1CCCCC1)CCCC2.